Ziftomenib 200 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 200 mg
Reference Brands: Komzifti (USA)
Category: Oncology Cancer Care
Ziftomenib is a small‑molecule menin inhibitor. It blocks the interaction between menin and MLL proteins, disrupting a pathway critical for the survival and proliferation of certain leukemia cells, especially those with NPM1 mutation or MLL rearrangement. It is used in adult patients with relapsed or refractory AML who have no satisfactory alternative treatment options.
Ziftomenib — third party manufacturing & bulk supply
Ziftomenib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ziftomenib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ziftomenib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ziftomenib is used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have an NPM1 mutation and have no satisfactory alternative treatment options. It works by targeting the genetic pathway driving the leukemia to slow disease progression.
It is made from the active pharmaceutical ingredient ziftomenib, a small-molecule menin inhibitor that disrupts the interaction between the Menin protein and KMT2A (MLL), which helps prevent the growth of leukemia cells.
The trade name is Komzifti.
Komzifti is manufactured by Kura Oncology in collaboration with Kyowa Kirin.
The generic name is ziftomenib.
The brand name is Komzifti.
It is manufactured in approved pharmaceutical facilities in the USA and Japan, with distribution depending on regulatory approvals.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
